California State Teachers Retirement System Myriad Genetics Inc Transaction History

California State Teachers Retirement System

  • $84.1 Billion
  • Q3 2024

A detailed history of California State Teachers Retirement System transactions in Myriad Genetics Inc stock. As of the latest transaction made, California State Teachers Retirement System holds 85,538 shares of MYGN stock, worth $1.18 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
85,538
Previous 87,758 2.53%
Holding current value
$1.18 Million
Previous $2.15 Million 9.09%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$23.97 - $28.6 $53,213 - $63,492
-2,220 Reduced 2.53%
85,538 $2.34 Million
Q2 2024

Aug 14, 2024
SELL
$17.98 - $25.47 $18,501 - $26,208
-1,029 Reduced 1.16%
87,758 $2.15 Million
Q1 2024

May 15, 2024
BUY
$17.59 - $23.59 $45,100 - $60,484
2,564 Added 2.97%
88,787 $1.89 Million
Q4 2023

Feb 13, 2024
SELL
$13.91 - $21.32 $51,133 - $78,372
-3,676 Reduced 4.09%
86,223 $1.65 Million
Q3 2023

Nov 14, 2023
SELL
$15.99 - $23.22 $139,624 - $202,757
-8,732 Reduced 8.85%
89,899 $1.44 Million
Q2 2023

Aug 21, 2023
SELL
$17.56 - $23.76 $37,666 - $50,965
-2,145 Reduced 2.13%
98,631 $2.29 Million
Q1 2023

May 09, 2023
SELL
$15.26 - $23.75 $16,480 - $25,650
-1,080 Reduced 1.06%
100,776 $2.34 Million
Q4 2022

Feb 14, 2023
BUY
$14.51 - $20.99 $19,138 - $27,685
1,319 Added 1.31%
101,856 $1.48 Million
Q3 2022

Nov 18, 2022
SELL
$18.21 - $27.88 $33,943 - $51,968
-1,864 Reduced 1.82%
100,537 $1.92 Million
Q2 2022

Aug 15, 2022
BUY
$16.45 - $25.88 $9,491 - $14,932
577 Added 0.57%
102,401 $1.86 Million
Q1 2022

May 16, 2022
SELL
$22.67 - $28.01 $167,213 - $206,601
-7,376 Reduced 6.75%
101,824 $2.57 Million
Q4 2021

Feb 15, 2022
BUY
$24.13 - $32.63 $103,541 - $140,015
4,291 Added 4.09%
109,200 $3.01 Million
Q3 2021

Nov 15, 2021
SELL
$29.97 - $36.66 $19,780 - $24,195
-660 Reduced 0.63%
104,909 $3.39 Million
Q2 2021

Aug 16, 2021
SELL
$25.39 - $32.61 $45,194 - $58,045
-1,780 Reduced 1.66%
105,569 $3.23 Million
Q1 2021

May 18, 2021
SELL
$19.92 - $31.6 $22,270 - $35,328
-1,118 Reduced 1.03%
107,349 $3.27 Million
Q4 2020

Feb 16, 2021
SELL
$12.16 - $19.77 $4,280 - $6,959
-352 Reduced 0.32%
108,467 $2.15 Million
Q2 2020

Aug 17, 2020
BUY
$10.69 - $16.49 $15,019 - $23,168
1,405 Added 1.31%
108,819 $1.23 Million
Q1 2020

May 13, 2020
SELL
$9.78 - $29.53 $11,853 - $35,790
-1,212 Reduced 1.12%
107,414 $1.54 Million
Q4 2019

Feb 14, 2020
SELL
$20.93 - $35.1 $21,516 - $36,082
-1,028 Reduced 0.94%
108,626 $2.96 Million
Q3 2019

Nov 15, 2019
BUY
$22.08 - $47.08 $36,476 - $77,776
1,652 Added 1.53%
109,654 $3.14 Million
Q2 2019

Aug 14, 2019
BUY
$22.67 - $35.0 $61,481 - $94,920
2,712 Added 2.58%
108,002 $3 Million
Q1 2019

May 09, 2019
SELL
$26.93 - $34.7 $121,965 - $157,156
-4,529 Reduced 4.12%
105,290 $3.5 Million
Q4 2018

Feb 13, 2019
BUY
$27.23 - $45.56 $220,944 - $369,673
8,114 Added 7.98%
109,819 $3.19 Million
Q3 2018

Nov 14, 2018
BUY
$37.57 - $50.34 $48,728 - $65,290
1,297 Added 1.29%
101,705 $4.68 Million
Q2 2018

Aug 14, 2018
BUY
$27.75 - $40.17 $26,640 - $38,563
960 Added 0.97%
100,408 $3.75 Million
Q1 2018

May 15, 2018
SELL
$28.83 - $41.01 $100,530 - $143,001
-3,487 Reduced 3.39%
99,448 $2.94 Million
Q4 2017

Feb 14, 2018
BUY
$28.45 - $37.14 $2,930 - $3,825
103 Added 0.1%
102,935 $3.54 Million
Q3 2017

Nov 13, 2017
BUY
$24.01 - $36.2 $2.47 Million - $3.72 Million
102,832
102,832 $3.72 Million

Others Institutions Holding MYGN

# of Institutions
253
Shares Held
90.5M
Call Options Held
100K
Put Options Held
34K
View Full List

About MYRIAD GENETICS INC

MYGN Quotes by TradingView
  • Ticker MYGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 80,634,800
  • Market Cap $1.11B
  • Description
  • Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...
More about MYGN
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email